Hot Stocks: Energy Transfer Partners, L.P. (NYSE:ETP), Statoil ASA (NYSE:STO), WESCO International Inc. (NYSE:WCC), Bristol-Myers Squibb Company (NYSE:BMY), Murphy Oil Corporation (NYSE:MUR)


On Wednesday shares of Energy Transfer Partners, L.P. (NYSE:ETP) closed at $55.30. Company’s sales growth for last 5 years was 56.70% and EPS growth for next 5 years is recorded as 6.00%. Energy Transfer Partners, L.P. (NYSE:ETP) announced that its Board of Directors has approved a $0.02 increase in its quarterly distribution to $1.015 per ETP common unit ($4.06 annualized) for the quarter ended March 31, 2015.

Statoil ASA (NYSE:STO) in last trading activity increased 0.44% to close at $20.47. Company weekly performance is 5.84% while its quarterly performance stands at 22.80%. Statoil ASA (NYSE:STO) is -34.44% away from its 52 week high. Despite challenging oil and gas prices in the quarter, Statoil (NYSE:STO) delivered Adjusted earnings of NOK 22.9 billion and NOK 7.0 billion after tax. Statoil reports a negative IFRS Net income of NOK 35.4 billion due to impairments.

On last trading day WESCO International Inc. (NYSE:WCC) increased 1.17% to close at $71.63. Its volatility for the week is 3.29% while volatility for the month is 2.24%. WCC’s sales growth for past 5 years was 11.30% and its EPS growth for past 5 years was 16.10%. WESCO International Inc. (NYSE:WCC) monthly performance is 1.96%. On April 27, WESCO International, Inc. (NYSE:WCC), announced that WESCO Distribution, Inc. has entered into a definitive agreement to acquire Hill Country Electric Supply. Closing is expected to occur in May 2015.

Bristol-Myers Squibb Company (NYSE:BMY) has 0.10% insider ownership while its institutional ownership stands at 72.60%. In last trading activity company’s stock closed at $64.29. Bristol-Myers Squibb Co. (NYSE:BMY) announced that the U.S. Food and Drug Administration or FDA has accepted for filing and review the supplemental Biologics License Application or sBLA for Opdivo(nivolumab)for the treatment of previously untreated patients with unresectable or metastatic melanoma. The FDA also granted Priority Review for this application. The projected FDA action date is August 27, 2015.

On last trading day Murphy Oil Corporation (NYSE:MUR) increased 1.63% to close at $49.19. Its volatility for the week is 2.13% while volatility for the month is 2.14%. MUR’s sales growth for past 5 years was -20.60% and its EPS growth for past 5 years was 8.90%. Murphy Oil Corporation (NYSE:MUR) monthly performance is 3.19%. Murphy Oil Corp. (NYSE:MUR) on Wednesday reported a first-quarter loss of $14.4 million, after reporting a profit in the same period a year earlier.


Leave a Reply

Your email address will not be published. Required fields are marked *